Literature DB >> 26201900

Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis.

Abby L Geis1, Hongni Fan1, Xinqun Wu2, Shaoguang Wu2, David L Huso3, Jaime L Wolfe4, Cynthia L Sears5, Drew M Pardoll6, Franck Housseau7.   

Abstract

UNLABELLED: Many epithelial cancers are associated with chronic inflammation. However, the features of inflammation that are procarcinogenic are not fully understood. Regulatory T cells (Treg) typically restrain overt inflammatory responses and maintain intestinal immune homeostasis. Their immune-suppressive activity can inhibit inflammation-associated cancers. Paradoxically, we show that colonic Tregs initiate IL17-mediated carcinogenesis in multiple intestinal neoplasia mice colonized with the human symbiote enterotoxigenic Bacteroides fragilis (ETBF). Depletion of Tregs in ETBF-colonized C57BL/6 FOXP3(DTR) mice enhanced colitis but diminished tumorigenesis associated with shifting of mucosal cytokine profile from IL17 to IFNγ; inhibition of ETBF-induced colon tumorigenesis was dependent on reduced IL17 inflammation and was independent of IFNγ. Treg enhancement of IL17 production is cell-extrinsic. IL2 blockade restored Th17 responses and tumor formation in Treg-depleted animals. Our findings demonstrate that Tregs limit the availability of IL2 in the local microenvironment, allowing the Th17 development necessary to promote ETBF-triggered neoplasia, and thus unveil a new mechanism whereby Treg responses to intestinal bacterial infection can promote tumorigenesis. SIGNIFICANCE: Tregs promote an oncogenic immune response to a common human symbiote associated with inflammatory bowel disease and colorectal cancer. Our data define mechanisms by which mucosal Tregs, despite suppressing excessive inflammation, promote the earliest stages of immune procarcinogenesis via enhancement of IL17 production at the expense of IFNγ production. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26201900      PMCID: PMC4592451          DOI: 10.1158/2159-8290.CD-15-0447

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  59 in total

1.  CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.

Authors:  Pushpa Pandiyan; Lixin Zheng; Satoru Ishihara; Jennifer Reed; Michael J Lenardo
Journal:  Nat Immunol       Date:  2007-11-04       Impact factor: 25.606

2.  Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.

Authors:  Lili Xu; Atsushi Kitani; Ivan Fuss; Warren Strober
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

3.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

4.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

5.  Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Authors:  Timothy J Harris; Joseph F Grosso; Hung-Rong Yen; Hong Xin; Marcin Kortylewski; Emilia Albesiano; Edward L Hipkiss; Derese Getnet; Monica V Goldberg; Charles H Maris; Franck Housseau; Hua Yu; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

6.  Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin.

Authors:  S Wu; K C Lim; J Huang; R F Saidi; C L Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.

Authors:  Arian Laurence; Cristina M Tato; Todd S Davidson; Yuka Kanno; Zhi Chen; Zhengju Yao; Rebecca B Blank; Françoise Meylan; Richard Siegel; Lothar Hennighausen; Ethan M Shevach; John J O'shea
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

8.  Risk factors of colorectal cancer in inflammatory bowel disease.

Authors:  P Bansal; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

9.  Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease.

Authors:  T P Prindiville; R A Sheikh; S H Cohen; Y J Tang; M C Cantrell; J Silva
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  55 in total

1.  Oral IL-10 suppresses colon carcinogenesis via elimination of pathogenicCD4+ T-cells and induction of antitumor CD8+ T-cell activity.

Authors:  Tao Gu; Magdia De Jesus; Heather C Gallagher; Thomas P Burris; Nejat K Egilmez
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

Review 2.  Insights into the role of the intestinal microbiota in colon cancer.

Authors:  Sofia Oke; Alberto Martin
Journal:  Therap Adv Gastroenterol       Date:  2017-02-01       Impact factor: 4.409

3.  The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells.

Authors:  Tingting Wang; Chaogang Fan; Anran Yao; Xingwei Xu; Guoxing Zheng; Yun You; Changying Jiang; Xueqiang Zhao; Yayi Hou; Mien-Chie Hung; Xin Lin
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

4.  Procarcinogenic regulatory T cells in microbial-induced colon cancer.

Authors:  Abby L Geis; Franck Housseau
Journal:  Oncoimmunology       Date:  2015-12-21       Impact factor: 8.110

Review 5.  Gut Microbiota, Inflammation, and Colorectal Cancer.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Annu Rev Microbiol       Date:  2016-09-08       Impact factor: 15.500

6.  Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy.

Authors:  Amy S Duffield; Maria Libera Ascierto; Robert A Anders; Janis M Taube; Alan K Meeker; Shuming Chen; Tracee L McMiller; Neil A Phillips; Haiying Xu; Aleksandra Ogurtsova; Alan E Berger; Drew M Pardoll; Suzanne L Topalian; Richard F Ambinder
Journal:  Blood Adv       Date:  2017-07-21

7.  Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.

Authors:  Maria Paula Roberti; Satoru Yonekura; Connie P M Duong; Marion Picard; Gladys Ferrere; Maryam Tidjani Alou; Conrad Rauber; Valerio Iebba; Christian H K Lehmann; Lukas Amon; Diana Dudziak; Lisa Derosa; Bertrand Routy; Caroline Flament; Corentin Richard; Romain Daillère; Aurélie Fluckiger; Isabelle Van Seuningen; Mathias Chamaillard; Audrey Vincent; Stephanie Kourula; Paule Opolon; Pierre Ly; Eugénie Pizzato; Sonia Becharef; Juliette Paillet; Christophe Klein; Florence Marliot; Filippo Pietrantonio; Stéphane Benoist; Jean-Yves Scoazec; Peggy Dartigues; Antoine Hollebecque; David Malka; Franck Pagès; Jérôme Galon; Ivo Gomperts Boneca; Patricia Lepage; Bernard Ryffel; Didier Raoult; Alexander Eggermont; Tom Vanden Berghe; François Ghiringhelli; Peter Vandenabeele; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2020-05-25       Impact factor: 53.440

Review 8.  The Role of the Gut Microbiome in Colorectal Cancer.

Authors:  Grace Y Chen
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

9.  Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer.

Authors:  Eleonora Timperi; Ilenia Pacella; Valeria Schinzari; Chiara Focaccetti; Luca Sacco; Francesco Farelli; Roberto Caronna; Gabriella Del Bene; Flavia Longo; Antonio Ciardi; Sergio Morelli; Anna Rita Vestri; Piero Chirletti; Vincenzo Barnaba; Silvia Piconese
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 10.  Immune Regulation of the Metastatic Process: Implications for Therapy.

Authors:  A de Mingo Pulido; B Ruffell
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.